FDA Adverse Event Malfunction Summary report: N

CONTOUR NEXT

MDR report key: 8721603 · Received June 21, 2019

Report

Report Number
1810909-2019-00261
Event Type
Malfunction
Date Received
June 21, 2019
Date of Event
May 19, 2019
Report Date
May 23, 2019
Manufacturer
ASCENSIA DIABETES CARE US INC.
Product Code
NBW
UDI-DI
00301939697010
PMA / PMN Number
K121190
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 0

BASED ON THE INFORMATION RECEIVED, CUSTOMER USED CONTOUR NEXT TEST STRIPS LOT # 8FPEG30A FOR THIS EVENT. SECTIONS D1, D2, D4, G1,2 CONTINUED, AND H4 HAVE BEEN CORRECTED TO REFLECT THE CORRECT PRODUCT INFORMATION.

Additional Manufacturer Narrative · 0

THE CUSTOMER DID NOT RETURN THE SUSPECTED PRODUCT. AN IN-HOUSE TESTING WAS PERFORMED USING THE IN-HOUSE CONTOUR NEXT METER WITH IN-HOUSE CONTOUR NEXT TEST STRIPS FROM LOT # 8FPEG30A, WHICH GAVE SATISFACTORY PERFORMANCE.

Additional Manufacturer Narrative · 1

THE PATIENT/FAMILY WAS THE INITIAL REPORTER, SO PERSONAL INFORMATION WAS NOT ENTERED. THIS EVENT IS RELATED TO MDRS 1810909-2019-00260, 1810909-2019-00262, 1810909-2019-00263, AND 1810909-2019-00264.

Description of Event or Problem · 1

AT 12:36 A.M., THE CUSTOMER OBTAINED A BLOOD GLUCOSE READING OF 289 MG/DL ON A CONTOUR NEXT METER. THE CUSTOMER HAD NO SYMPTOMS OF HYPERGLYCEMIA. WITHIN 10 MINUTES, THE CUSTOMER PERFORMED A REPEAT TESTING ON THE BREEZE2 METER AND OBTAINED A READING OF 40-50% LOWER COMPARED TO THAT OBTAINED ON THE CONTOUR NEXT METER. THE SPECIFIC READING OBTAINED ON THE BREEZE2 METER WAS NOT PROVIDED. THERE WAS NO ALLEGATION OF AN ADVERSE EVENT. THE CUSTOMER WAS ADVISED TO RETURN THE TEST STRIPS FOR EVALUATION. A REPLACEMENT METER KIT WAS SENT TO THE CUSTOMER. SINCE THE STRIP INFORMATION WAS NOT PROVIDED, THIS REPORT WILL BE SUBMITTED UNDER THE METER INFORMATION.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
514862 CONTOUR NEXT BLOOD GLUCOSE TEST STRIPS NBW ASCENSIA DIABETES CARE US INC. 7312 8FPEG30A 00301939697010

Patients

Seq Age Sex Outcome Treatment
1 60 YR